Your browser doesn't support javascript.
loading
Deletion of donor-reactive T cell clones after human liver transplant.
Savage, Thomas M; Shonts, Brittany A; Lau, Saiping; Obradovic, Aleksandar; Robins, Harlan; Shaked, Abraham; Shen, Yufeng; Sykes, Megan.
Afiliação
  • Savage TM; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Shonts BA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Lau S; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Obradovic A; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
  • Robins H; Fred Hutchinson Cancer Research Center, Adaptive Biotechnologies, Inc., Seattle, Washington.
  • Shaked A; Division of Transplant Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Shen Y; Departments of Systems Biology and Biomedical Informatics, Columbia University, New York, New York.
  • Sykes M; Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
Am J Transplant ; 20(2): 538-545, 2020 02.
Article em En | MEDLINE | ID: mdl-31509321
ABSTRACT
We recently developed a high throughput T cell receptor ß chain (TCRß) sequencing-based approach to identifying and tracking donor-reactive T cells. To address the role of clonal deletion in liver allograft tolerance, we applied this method in samples from a recent randomized study, ITN030ST, in which immunosuppression withdrawal was attempted within 2 years of liver transplantation. We identified donor-reactive T cell clones via TCRß sequencing following a pre-transplant mixed lymphocyte reaction and tracked these clones in the circulation following transplantation in 3 tolerant and 5 non-tolerant subjects. All subjects showed a downward trend and significant reductions in donor-reactive TCRß sequences were detected post-transplant in 6 of 8 subjects, including 2 tolerant and 4 non-tolerant recipients. Reductions in donor-reactive TCRß sequences were greater than those of all other TCRß sequences, including 3rd party-reactive sequences, in all 8 subjects, demonstrating an impact of the liver allograft after accounting for repertoire turnover. Although limited by patient number and heterogeneity, our results suggest that partial deletion of donor-reactive T cell clones may be a consequence of liver transplantation and does not correlate with success or failure of early immunosuppression withdrawal. These observations underscore the organ- and/or protocol-specific nature of tolerance mechanisms in humans.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Terapia de Imunossupressão / Deleção Clonal Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Terapia de Imunossupressão / Deleção Clonal Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article